Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Vicore Pharma Holding AB

Closing information (x1000 SEK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 109,346 Less Arrow 0 Equal arrow 0
Financial expenses 8 More Arrow 358 More Arrow 476
Earnings before taxes -168,890 Less Arrow -311,326 More Arrow -288,806
EBITDA -191,946 Less Arrow -318,150 More Arrow -287,368
Total assets 1,203,108 Less Arrow 497,838 Less Arrow 338,007
Current assets 1,203,108 Less Arrow 495,595 Less Arrow 269,790
Current liabilities 72,908 Less Arrow 38,781 More Arrow 46,292
Equity capital 1,129,329 Less Arrow 455,389 Less Arrow 289,083
- share capital 117,290 Less Arrow 55,861 Less Arrow 40,924
Employees (average) 27 Less Arrow 25 Less Arrow 21

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 93.9% Less Arrow 91.5% Less Arrow 85.5%
Turnover per employee 4,050 Less Arrow 0 Equal arrow 0
Profit as a percentage of turnover -154.5%
Return on assets (ROA) -14.0% Less Arrow -62.5% Less Arrow -85.3%
Current ratio 1650.2% Less Arrow 1277.9% Less Arrow 582.8%
Return on equity (ROE) -15.0% Less Arrow -68.4% Less Arrow -99.9%
Change turnover 109,346 Less Arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 2 More Arrow 4 More Arrow 5
Chg. No. of employees % 8% More Arrow 19% More Arrow 31%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.